Skip to main content
LobbyMap

Horizon Therapeutics

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
59/100
Moderate Influence
$5.3M
Total Lobby Spend
4
Policy Issues
4
Lobbyists
2
Revolving Door

Horizon Therapeutics reported $5.3 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Housing & Urban Development
Small Business Administration
White House Office
Environmental Protection Agency
Federal Trade Commission
Dept of Transportation
Food & Drug Administration

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecJones Day
PHAHCRGOV
2$212K
2024 Jul-SepPrime Policy Group
PHAGOVMED
3$215K
2024 Apr-JunInvariant LLC
GOVMEDHCR
4$288K
2024 Jan-MarCassidy & Associates
PHAHCRMED+1
3$291K
2023 Oct-DecK&L Gates
HCRGOV
3$217K
2023 Jul-SepSteptoe & Johnson
HCRPHAGOV
4$242K
2023 Apr-JunFranklin Square Group
HCRMEDGOV
3$247K
2023 Jan-MarPeck Madigan Jones
MEDPHA
4$214K

Horizon Therapeutics Lobbying FAQ

Horizon Therapeutics has spent $5.3M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Horizon Therapeutics lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Horizon Therapeutics has an Influence Score of 59/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Horizon Therapeutics employs 4 registered lobbyists, of whom 2 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Horizon Therapeutics has contacted 7 government entities as part of their lobbying activities, including Dept of Housing & Urban Development, Small Business Administration, White House Office.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.